Similar articles

• Activation of striatal neurons by dexamphetamine is antagonized by degeneration of striatal dopaminergic terminals.

  Warenycia MW, McKenzie GM. Warenycia MW, et al. J Neural Transm. 1987;70(3-4):217-32. doi: 10.1007/BF01253599. J Neural Transm. 1987. PMID: 3119772
• Electrochemical detection of dopamine release in the striatum of freely moving hamsters.

  Forni C, Nieoullon A. Forni C, et al. Brain Res. 1984 Apr 9;297(1):11-20. doi: 10.1016/0006-8993(84)90538-9. Brain Res. 1984. PMID: 6144355
• Long-term effects of nigro-striatal denervation of striatal [3H]haloperidol binding.

  Feuerstein C, Demenge P, Barrette G, Silice C, Guerin B, Mouchet P. Feuerstein C, et al. Eur J Pharmacol. 1981 Dec 17;76(4):457-60. doi: 10.1016/0014-2999(81)90122-9. Eur J Pharmacol. 1981. PMID: 6799306 No abstract available.
• Reversal of nigrostriatal-lesion-induced receptor alterations by grafting of fetal mesencephalic dopaminergic neurons.

  Wamsley JK, Dawson TM, Dawson VL, Hunt MA, Fisher LJ, Gage FH. Wamsley JK, et al. Adv Exp Med Biol. 1991;287:221-35. doi: 10.1007/978-1-4684-5907-4_18. Adv Exp Med Biol. 1991. PMID: 1759609 Review. No abstract available.
• 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome.

  Ungerstedt U. Ungerstedt U. Pharmacol Ther B. 1976;2(1):37-40. doi: 10.1016/0306-039x(76)90016-7. Pharmacol Ther B. 1976. PMID: 772721 Review. No abstract available.